{
    "nctId": "NCT05829707",
    "briefTitle": "Long-term Outcomes of Breast Cancer Patients After Wound Infiltration Analgesia",
    "officialTitle": "Long-term Outcomes of Breast Cancer Patients Receiving Levobupivacaine Wound Infiltration or Diclofenac for Postoperative Pain Relief",
    "overallStatus": "COMPLETED",
    "conditions": "Postoperative Analgesia, Hand Strength, Health Related Quality of Life, Chronic Shoulder Pain, Breast Cancer Female, Surgical Wound Infiltration, Lymph Node Dissection",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE4",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 120,
    "primaryOutcomeMeasure": "Postoperative analgesia",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Breast cancer patients whose disease requires axillary lymph node dissection\n* who consented to participate in the study\n* aged 30 - 75\n* The patient is able to understand all three methods of analgesia\n* Patients can receive any of the study drugs\n* Able to understand and complete questionnaires on quality of life and shoulder pain\n\nExclusion Criteria:\n\n* Age \\<30 years - \\>75 years\n* Patients who refused to participate in the study (at any stage of the study)\n* Patients who after histological analysis did not require axillary lymph node dissection\n* Patients with known intolerance to study drugs\n* Patients who unintentionally removed wound infiltration catheters.\n* Patients who required surgical reintervention during the study period\n* Patients having adverse reactions to any study drug.",
    "sex": "FEMALE",
    "minimumAge": "30 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}